Skip to content

Antiseptic Treatment for Reduction of nosocomial menigitis

Antiseptic Treatment for Reduction of nosocomial menigitis - AntiRedMen

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00017247
Enrollment
544
Registered
2019-05-06
Start date
2019-05-06
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z98.2

Interventions

Group 1: The control or standard of care Group receives a conventional Dressing after Insertion of the EVD/LD (external ventricular drainage (EVD) / lumbar drainage (LD)) under sterile conditions. tha

Sponsors

UMG
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Indication for the installation of an external ventricular drainage or a lumbar drainage • Age > 18 years

Exclusion criteria

Exclusion criteria: • Allergy to chlorhexidine • not granted or withdrawn consent to the evaluation of the specific data • prefinal status

Design outcomes

Primary

MeasureTime frame
The number of infections relative to the number of patients, as compared to the total number of patients during the period of observation (incidence).

Secondary

MeasureTime frame
a. the drainage-associated infection rate, given as meningoventriculitis / 1000 drainage days according to national and international standard definition (according to criteria of the CDC, KISS, modified according to Scheithauer et Bürgel), b. the rate of adverse effects on application of antiseptics, c. the influence of the antiseptic application on the skin microbiome of the affected region.

Countries

Germany

Contacts

Public ContactSimone Scheithauer

UMG

simone.scheithauer@med.uni-goettingen.de+49551394963

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026